Todisco Joseph 4

What Happened
Joseph Todisco, CEO of CorMedix (CRMD), was credited with 77,156 performance stock units (PSUs) effective February 4, 2026. The Form 4 reports an award/acquisition (code A) at $0.00 per share (no cash paid). This is a compensation award, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-02-04; Form 4 filed: 2026-02-06 (timely filing).
• Transaction type/code: Award/Grant (A).
• Shares/units: 77,156 PSUs granted; reported acquisition price $0.00 (no cash exchanged).
• Shares owned after transaction: not specified in this filing.
• Footnote: These PSUs represent achievement of the performance conditions for the first of three performance periods tied to PSUs granted Jan 2, 2025; they remain subject to time-based vesting per the Compensation Committee (see footnote F1).
• No indication of a 10b5-1 plan, tax-withholding sale, or immediate sale of shares.

Context
PSUs are a form of equity compensation that convert into shares if performance and any time-based vesting conditions are met. Awards like this reflect company compensation decisions and do not by themselves signal an insider buying or selling shares in the market.